|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4035 | |
| C07D 209/46 | |||
| C07D 209/48 | |||
| C07D 403/04 | |||
| C07D 403/06 | |||
| A61P 11/06 | |||
| A61P 29/00 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| A61P 37/06 |
| (11) | Number of the document | 2263669 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10176420.7 |
| Date of filing the European patent application | 2000-11-09 | |
| (97) | Date of publication of the European application | 2010-12-22 |
| (45) | Date of publication and mention of the grant of the patent | 2012-02-08 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 165168 P | 1999-11-12 | US | |
| 590344 | 2000-06-08 | US | |
| 708199 | 2000-11-08 | US |
| (72) |
Man, Hon-Wah, US
Muller, George W., US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit New Jersey 07901,
US
|
| (54) | Pharmaceutically active isoindoline derivatives |
| Pharmaceutically active isoindoline derivatives |